Literature DB >> 2415275

The pathogenesis of Graves' ophthalmopathy.

P Kendall-Taylor.   

Abstract

The pathology of the orbital changes in Graves' ophthalmopathy (GO) has been discussed in detail. The target tissue is the eye muscle and the damage probably results from autoimmune processes. Cell-mediated immune responses have been demonstrated and an antibody to eye muscle is detectable in 70% of patients. There is no direct evidence for an effect of thyroid hormones or TSH on orbital tissues in GO. The relation between GO and autoimmune thyroid disease is discussed. Present evidence suggests that in GO autoimmune responses are directed to orbital tissue antigens and do not cross-react with thyroid antigens. Clinical studies suggest that all patients with hyperthyroidism have some abnormality of eye muscle, whereas not all patients with ophthalmopathy have evidence of thyroid disease. It is not possible at the present time to be certain whether GO is an integral part of Graves' disease or a separate entity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2415275     DOI: 10.1016/s0300-595x(85)80037-2

Source DB:  PubMed          Journal:  Clin Endocrinol Metab        ISSN: 0300-595X


  11 in total

Review 1.  Immunosuppressant therapy of thyroid eye disease.

Authors:  G Kahaly; J Beyer
Journal:  Klin Wochenschr       Date:  1988-11-01

2.  Intravenous methylprednisolone in the treatment of Graves' ophthalmopathy.

Authors:  P Kendall-Taylor; A L Crombie; A M Stephenson; M Hardwick; K Hall
Journal:  BMJ       Date:  1988-12-17

3.  HLA-DR4 associated response to corticosteroids in Graves' ophthalmopathy patients.

Authors:  R van der Gaag; W M Wiersinga; L Koornneef; M P Mourits; M F Prummel; A Berghout; R R de Vries; G M Schreuder; J D'Amaro
Journal:  J Endocrinol Invest       Date:  1990-06       Impact factor: 4.256

4.  MicroRNA-146a contributes to CD4+ T lymphocyte differentiation in patients with thyroid ophthalmopathy.

Authors:  Wen-Juan Yang; Peng-Fei Ma; Shu-Ping Li; Hong Su; Yun-Jia Liu
Journal:  Am J Transl Res       Date:  2017-04-15       Impact factor: 4.060

Review 5.  Graves' ophthalmopathy: what is the evidence for extraocular muscle specific autoantibodies.

Authors:  R van der Gaag; R Vernimmen; N Fiebelkorn; M C van Dierendonck; A Kijlstra
Journal:  Int Ophthalmol       Date:  1990-01       Impact factor: 2.031

6.  Improvement of infiltrative ophthalmopathy in parallel with decrease of thyroid-stimulating antibody (TSAb) activity in two patients with hypothyroid Graves' disease.

Authors:  H Tamaki; N Amino; Y Iwatani; K Miyai
Journal:  J Endocrinol Invest       Date:  1989-01       Impact factor: 4.256

7.  The influence of surgery on endocrine ophthalmopathy.

Authors:  A Frilling; P E Goretzki; M Grussendorf; M Erbslöh; H D Röher
Journal:  World J Surg       Date:  1990 May-Jun       Impact factor: 3.352

8.  Circulating monocyte migration inhibitory factor in serum of Graves' ophthalmopathy patients: a parameter for disease activity?

Authors:  R van der Gaag; L Broersma; M P Mourits; L Koornneef; W M Wiersinga; M P Prummel; A Berghout
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

9.  Palmitate induced secretion of IL-6 and MCP-1 in orbital fibroblasts derived from patients with thyroid-associated ophthalmopathy.

Authors:  Ji-Sun Paik; Won-Kyung Cho; Eun-Hye Oh; Seong-Beom Lee; Suk-Woo Yang
Journal:  Mol Vis       Date:  2012-06-04       Impact factor: 2.367

Review 10.  Critical Appraisal on Orbital Decompression for Thyroid Eye Disease: A Systematic Review and Literature Search.

Authors:  Konstadinos G Boboridis; Jimmy Uddin; Dimitrios G Mikropoulos; Catey Bunce; George Mangouritsas; Irini C Voudouragkaki; Anastasios G P Konstas
Journal:  Adv Ther       Date:  2015-07-23       Impact factor: 3.845

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.